2477 — WellCell Holdings Co Income Statement
0.000.00%
- HK$7.30bn
- HK$7.22bn
- CNY278.22m
Annual income statement for WellCell Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 196 | 203 | 227 | 256 | 278 |
Cost of Revenue | |||||
Gross Profit | 94.5 | 87.6 | 66.7 | 61.6 | 56.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 160 | 173 | 196 | 232 | 257 |
Operating Profit | 35.2 | 30.5 | 30.1 | 24 | 20.9 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 34.7 | 30.1 | 29.3 | 23.1 | 21.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 29.7 | 25.5 | 24.3 | 20.4 | 20.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 29.7 | 25.5 | 24.3 | 20.4 | 20.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 29.7 | 25.5 | 24.3 | 20.4 | 20.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.031 | 0.032 | 0.033 | 0.033 | 0.026 |